NueStack™ — Pre-Built Stacks. Expertly Assembled.
NueCell Bio gives clients access to experienced design, development, and CMC expertise. By combining scientific excellence, strong quality systems, scalable operations, and “customer first” engagement, NueCell Bio helps accelerate the journey from scientific discovery to clinical delivery.
NueStack™ is how we package that expertise for every program—a library of proven, modular technology stacks deployed across modalities and configured to your program’s scale, workflow, and target product profile, giving every program a validated starting point instead of a blank page. Pre-tested stacks address a program’s development needs, expertly assembled and tailored by a team with decades of practical experience.
Why NueStack
- Process development is facilitated by NueStacks
- Each program starts on a solid foundation
- Pre-tested NueStack modules allow skipping the riskiest months of process development
- Standardized unit operations leave time and resources to customize what’s necessary
- Team know-how generated by decades of hands-on experience
Pre-Built Starting Points
Delivering Bespoke Outcomes
The NueStack™ framework provides proven technology stacks that expedite development and manufacturing while remaining fully adaptable to your specific methods, modality, and scale.
-
Blood Cells
-
iPSC
-
Cell Engineering
-
Genome Editing
-
Cell Banking
-
Analytics
Key Features
-
Easily integrable into existing processes
-
Flexible customization to meet the TPP
-
Expert team with decades of experience
Impact
-
Faster timelines, reduced cost & risk
-
Consistency & quality across manufacturing sites
-
Skip the blank page by starting with a solid foundation
How NueStacks™ Work
Select Your Modules
-
Blood Cells
-
iPSC
-
Cell Engineering
-
Genome Editing
-
Cell Banking
-
Analytics
Expert Assembly of Technology Stacks
- Assembly of your products stack from over 100 individual components
- Process tuned to your scale & goals
- Practical know-how via decades of experience
Your Bespoke Process
-
Faster
From concept to proven process, without the blank-page penalty
-
Lower risk
Pre-tested stacks eliminate the riskiest unknowns in early development
-
Bespoke
Tailored to your modality, scale, and clinical strategy, not one-size-fits-all
Behind Each Module – A Qualified Technology Stack
Every NueStack™ module is built from several vetted technology layers stacked together, and each layer is already proven on its own. Take reprogramming, for example: it draws on GMP-compatible reagents (xeno-free media, GMP-grade vectors), source-matched SOPs locked to the specific starting material, in-process checkpoints, and a validated release panel covering pluripotency, vector clearance, and identity confirmation.
Each module is supported by technology stacks such as bioprocessing, cell engineering, gene editing, etc.- each with its own reagents, methods, in-process tests, and qualified assays already locked and documented.
Every Layer Is a Priced, Documented Unit
-
Priced
unit price and turnaround fixed at the layer level
-
Defined Deliverable
report, data package, and release criteria specified per layer
-
Configurable
add, drop, or swap layers without re-scoping the program
-
Quotable in Days
selections roll straight into a costed program plan
Backed by Deep Scientific Expertise
150+ peer-reviewed publications across stem cells, iPSC, gene editing, and translational CMC, alongside active involvement and participation in international scientific societies and standardization bodies. Most recently: “Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies” (Stem Cell Reports, 2026).
Built for the Space Between Discovery and GMP
Cell source decisions, cellular engineering, and manipulation that require early decisions that can be scaled from early discovery to commercial manufacturing.
Reprogramming and gene-editing platforms matched to your biology and target product profile, not chosen for convenience, drawing on decades of hands-on toolbox depth across modalities.
Processes and analytics are built with cGMP-ready raw materials, scaled-down models, and qualified assays, so GMP technology transfer is a replication exercise, not a reinvention.
Gap assessments, QbD-driven workflows, and multiple critical-step coverage de-risk the highest-cost decisions before clinical entry.
How NueCell Bio Delivers on the Science
Two decades after iPSCs were first described, their advantage is clear and significant: they can give rise to almost any cell type in the body, which makes allogeneic therapies far more practical to manufacture and deliver at scale. That promise is now becoming real. Japan has granted conditional approval to two iPSC-derived therapies, and more programs are advancing through the clinic globally.
Dr. Uma Lakshmipathy, Co-founder & Chief Science Officer
iPSCs have complex biology. NueStack™ was developed so that complexity doesn't have to be solved from scratch for every program. It captures our team's know-how, built over years of hands-on project work, and organizes it into pre-designed modules we can assemble quickly. A new program starts most of the way there, not at a blank page.
OUR EXPERTISE
Wide-Ranging Modality Expertise
Cell Types
- Primary cells (T, NK, Myeloid, etc.)
- Stem & progenitor cells (HSC, PSC, MSC, etc.)
- Specialized cells (differentiated stem cells, primary therapeutic cells)
Product architecture
- Autologous
- Adherent
- Scale-up
- Allogeneic
- Suspension
- Scale-out
Engineering Capabilities
- Gene editing
- Viral delivery
- Non-viral delivery
- Cellular reprogramming